Sort   by:  
 Page size 
UnknownRole of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load.
Not available
S-EPMC11233987 | biostudies-literature
UnknownIdentification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.
Not available
S-EPMC5844224 | biostudies-literature
UnknownMulti-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries.
Not available
S-EPMC12330429 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
Sort   by:  
 Page size